What we sell (raw material)
Microalgae biomass and ingredients for research and development of health products; custom R&D collaborations. Specification on request.
Market and demand: Europe · global · LATAM
Europe: a strong biotech ecosystem and interest in sustainable biofactories and natural compounds.
Global: an emerging field; microalgae are studied as a source of antioxidants, antivirals and as a protein expression system.
LATAM: growing biomedical and biotechnology research capacity.
What is being researched
Recombinant protein production in Chlamydomonas, antioxidant/anti-inflammatory compounds and new microalgae bioactives with therapeutic potential (at the research stage).
Key compounds
Recombinant proteinsAntioxidantsFatty acidsBioactive polysaccharides
Related species
FAQ
It is an emerging field: they are studied as a source of bioactives and as biofactories to produce proteins; several applications are at the research stage.